LifeMD (LFMD)
(Delayed Data from NSDQ)
$6.57 USD
-0.24 (-3.52%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $6.58 +0.01 (0.15%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LFMD 6.57 -0.24(-3.52%)
Will LFMD be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for LFMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LFMD
4 Stocks to Keep a Tab on for Amazing Earnings Acceleration
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
LFMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates
Lilly (LLY) Starts Website to Help Access Tirzepatide Drugs
Doximity (DOCS) Surpasses Q1 Earnings and Revenue Estimates
Other News for LFMD
Craig-Hallum Sticks to Their Buy Rating for LifeMD (LFMD)
Medifast: GLP-1 Fears Are Overblown, But Proof Points For Turnaround Are Still Missing
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD Launches Commercial Health Insurance Acceptance for its Primary Care Services, Including Weight Management
LifeMD launches private health insurance acceptance for primary care services